{
    "2021-12-28": [
        [
            {
                "time": "",
                "original_text": "万泰生物：万泰沧海近日收到赛诺菲发来的《关于终止新型轮状病毒疫苗许可协议的通知函》，万泰沧海已根据协议约定收到预付授权许可费1000万美元并履行了相关义务，此次交易的终止不影响该笔款项的收取权利，不会",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "赛诺菲",
                        "新型轮状病毒疫苗",
                        "许可协议终止",
                        "1000万美元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "万泰生物：终止授权赛诺菲巴斯德公司进行新型轮状病毒疫苗开发、生产及商业化",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "赛诺菲巴斯德",
                        "新型轮状病毒疫苗",
                        "终止授权"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "九价HPV“一苗难求”催生黄牛月入上万，国产何时可实现替代",
                "features": {
                    "keywords": [
                        "九价HPV",
                        "一苗难求",
                        "黄牛",
                        "国产替代"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}